Weight loss medicines lead to 'Ozempic face'. A Korean biotech company now has a solution
Kort samengevat
Chief Executive Officer Lee Whan Chul said L&C Bio developed the technology around five years ago and holds patents in South Korea, the United States and China.
Verder lezen bij de bron
Bekijk het volledige nieuwsbericht rechtstreeks bij Business Today.
Lees het volledige bericht ↗